Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3986307
Max Phase: Preclinical
Molecular Formula: C45H48ClN5O8S
Molecular Weight: 854.43
Molecule Type: Small molecule
Associated Items:
ID: ALA3986307
Max Phase: Preclinical
Molecular Formula: C45H48ClN5O8S
Molecular Weight: 854.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(CCC5OCCO5)c([N+](=O)[O-])c4)c(Oc4ccc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1
Standard InChI: InChI=1S/C45H48ClN5O8S/c1-45(2)17-15-33(39(28-45)30-3-7-34(46)8-4-30)29-49-19-21-50(22-20-49)35-9-12-38(42(26-35)59-36-10-13-40-32(25-36)16-18-47-40)44(52)48-60(55,56)37-11-5-31(41(27-37)51(53)54)6-14-43-57-23-24-58-43/h3-5,7-13,16,18,25-27,43,47H,6,14-15,17,19-24,28-29H2,1-2H3,(H,48,52)
Standard InChI Key: WHIXIPPWXNHPEA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 854.43 | Molecular Weight (Monoisotopic): 853.2912 | AlogP: 8.73 | #Rotatable Bonds: 13 |
Polar Surface Area: 156.34 | Molecular Species: ACID | HBA: 10 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.16 | CX Basic pKa: 7.96 | CX LogP: 7.56 | CX LogD: 7.68 |
Aromatic Rings: 5 | Heavy Atoms: 60 | QED Weighted: 0.09 | Np Likeness Score: -0.82 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):